Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Creative Diagnostics advances IgM diagnostic testing with human hybrid monoclonal antibodies
, /in Product News /by panglobalCreative Diagnostics has launched a comprehensive range of human hybrid IgM control monoclonal antibodies designed to overcome critical challenges in diagnostic assay development. The new product line addresses the persistent difficulty of sourcing reliable IgM-positive control materials for infectious disease testing across multiple pathogens including CMV, HSV, measles, mumps, rubella, and varicella-zoster virus.
Azenta Life Sciences launches enhanced FreezerPro system for improved sample management
, /in Product News /by panglobalLaboratory sample tracking reaches new levels of precision and efficiency with the latest iteration of Azenta Life Sciences’ web-based inventory management platform, addressing critical challenges in biological sample integrity and regulatory compliance.
Alithea Genomics unveils extraction-free platform for massive-scale drug screening
, /in Product News /by panglobalSwiss-American biotech firm Alithea Genomics has launched MERCURIUS™ Total DRUG-seq, an innovative extraction-free transcriptome profiling platform designed to accelerate high-throughput compound screening and target validation through unprecedented multiplexing capabilities. The new library preparation kit represents a significant advancement over the company’s existing MERCURIUS™ 3’ DRUG-seq technology, capturing complete transcriptomes including long non-coding RNAs with full-length […]
Werfen commences European commercialisation of award-winning GEM Premier 7000 haemolysis detection system
, /in Product News /by panglobalWerfen has announced the European expansion of its breakthrough GEM Premier 7000 with iQM3 blood gas testing system, following successful clinical adoption across North America. The system addresses a critical gap in point-of-care diagnostics by integrating real-time haemolysis detection – a first in blood gas analysis technology.
Amsbio launches GenePORTER Gold transfection reagent for enhanced gene delivery
, /in Product News /by panglobalAmsbio has introduced GenePORTER Gold, a lipid-based gene transfection reagent designed to deliver exceptional efficiency across a broad spectrum of cell lines whilst minimising cytotoxicity.
Bio-Rad expands droplet digital PCR portfolio with four new platforms
, /in Product News /by panglobalBio-Rad Laboratories has significantly bolstered its digital PCR capabilities through the launch of four new Droplet Digital™ PCR (ddPCR™) platforms, combining internal development with strategic acquisition assets from Stilla Technologies. The expansion positions the California-based company at the forefront of absolute quantification technologies for clinical and research applications.
Sartorius Stedim Biotech partners with Nanotein Technologies to advance immune cell manufacturing
, /in E-News /by panglobalSartorius Stedim Biotech has secured exclusive global distribution rights for NanoSpark® immune cell activation reagents, investing up to US$3 million in Nanotein Technologies whilst establishing a joint development programme targeting enhanced T cell and NK cell manufacturing workflows for cellular therapy applications.
Antibodies.com scales operations with huge expansion of Cambridge headquarters
, /in E-News /by panglobalBiological reagent supplier Antibodies.com has made a strategic relocation to Cambridge Technopark, which reflects sustained global growth, with its customer base tripling over five years to serve over 5,000 research institutions worldwide across more than 100 countries.
Novo Nordisk appoints new chief executive as pharma giant restructures R&D operations
, /in E-News /by panglobalDanish pharmaceutical giant Novo Nordisk has appointed Maziar Mike Doustdar as chief executive officer, bringing his proven track record of doubling international sales over the past decade. The leadership transition coincides with strategic R&D consolidation as the company positions itself to address rapidly developing diabetes and obesity markets.
Enhanced Genomics partnership unlocks hidden Alzheimer’s targets through breakthrough 3D multi-omics
, /in E-News /by panglobalEnhanced Genomics has partnered with Cambridge University’s ALBORADA Drug Discovery Institute to identify novel therapeutic targets for Alzheimer’s disease using advanced 3D multi-omics technology. The collaboration has already yielded multiple previously undetectable targets, potentially accelerating drug discovery timelines across neurodegenerative diseases.